Circulating mutant DNA to assess tumor dynamics

Keywords

Circulating tumor DNA, Colorectal cancer, Somatic cell, Cancer, DNA

References

• Circulating nucleic acids (CNAs) and cancer--a survey.Michael Fleischhacker, B. Schmidt — 2007
• BEAMing: single-molecule PCR on microparticles in water-in-oil emulsionsFrank Diehl, Meng Li, Yiping He — 2006
• Emerging molecular markers of cancerDavid Sidransky — 2002
• Detection and quantification of mutations in the plasma of patients with colorectal tumors.Frank Diehl, Meng Li, Devin Dressman — 2005
• Serial assessment of human tumor burdens in mice by the analysis of circulating DNA.Carlo Rago, David L. Huso, Frank Diehl — 2007
• Isolation of rare circulating tumour cells in cancer patients by microchip technologySunitha Nagrath, Lecia V. Sequist, Shyamala Maheswaran — 2007
• Advanced sequencing technologies: methods and goalsJay Shendure, Robi D. Mitra, Chris Varma — 2004
• Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal CancerMitchell J. Goldstein, Edith P. Mitchell — 2005
• Tumor microenvironment: The role of the tumor stroma in cancerHanchen Li, Xueli Fan, JeanMarie Houghton — 2007
• Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance.Emmanuelle Gormally, Élodie Caboux, Paolo Vineis — 2007
• Circulating tumor cells, disease progression, and survival in metastatic breast cancer.Massimo Cristofanilli, G. Thomas Budd, Matthew J. Ellis — 2004
• Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variationsDevin Dressman, Hai Yan, Giovanni Traverso — 2003
• Circulating Nucleic Acids in Plasma or Serum (CNAPS) as Prognostic and Predictive Markers in Patients with Solid NeoplasiasGeorg Goebel, Marion Zitt, Matthias Zitt — 2005
• Mutational analysis using oligonucleotide microarraysJ. Hacia, Francis S. Collins — 1999
• The Genomic Landscapes of Human Breast and Colorectal CancersLaura D. Wood, D. Williams Parsons, Siân Jones — 2007

Cited by

• Uterine cervix carcinoma: recent biological data and update for improving follow-up and treatment.Mejía-Gómez Javier, Xavier Sastre‐Garau — 2012
• Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non–Small Cell Lung Cancer PatientsT. Yung, K.C. Chan, Tony Mok — 2009
• A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancersИ.А. Гвоздева — 2013
• Outcomes and endpoints in trials of cancer treatment: the past, present, and future.Fahad Droma, Hanifa Bulyaba, Joseph Ssebwato — 2015
• ESR1 mutations in circulating plasma tumor DNA from metastatic breast cancer patientsKawakami Kohei, 川上 耕平 — 2015
• Detection of circulating tumor DNA in patients with advanced non-small cell lung cancerAnh Quoc Nguyen, Michael Anshel — 2016
• Liquid Biopsy: A Future Tool for Posttreatment Surveillance in Head and Neck Cancer?Nurten Ükelgi — 2016
• Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancerLouis D. Rubin — 2017
• Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatmentRobert E. Lipsey — 2017
• Emerging uses of circulating tumor DNA in advanced stage non-small cell lung cancer.Silvia Fiore, Barbara Ruffino, Mariachiara Zanetti — 2017
• Centrifugation-free extraction of circulating nucleic acids using immiscible liquid under vacuum pressureHoyoon Lee, Wonhwi Na, Chanhee Park — 2018
• The Clinical Landscape of Circulating Tumor DNA in Gastrointestinal MalignanciesLyndsay Attebery — 2018
• Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patientsGahee Park, Joo Kyung Park, Dae‐Soon Son — 2018
• Liquid Biopsy in Prostate Cancer: Circulating Tumor Cells and Beyond欧爱玲, 张铭, 赵莉苹 — 2018
• Pt-induced crosslinks promote target enrichment and protection from serum nucleases眞理子 玉井 — 2018
• TNER: a novel background error suppression method for mutation detection in circulating tumor DNACarlos Alvar Ezquerra, José Manuel Lucía Megías — 2018
• ASO Author Reflections: Circulating Tumor DNA in Peritoneal CarcinomatosisSébastien Faure — 2018
• Clinical Validation of a Cell-Free DNA Gene Panel.Lars Bojer Madsen — 2019
• Application of liquid biopsy for surgical management of pancreatic cancerJosé Alcalá-Zamora — 2020
• Opportunities on the horizon for the management of early colon cancer.szaboli — 2023

Related papers

• Two Lotus japonicus symbiosis mutants impaired at distinct steps of arbuscule development.Martin Groth, Sonja Kosuta, Caroline Gutjahr — 2013
• Thirty-Day Morbidity After Simultaneous Resection of Colorectal Cancer and Colorectal Liver Metastasis: American College of Surgeons NSQIP Analysis.Rebecca A. Snyder, Scarlett Hao, William Irish — 2020
• Suppressors of the secY24 mutation: identification and characterization of additional ssy genes in Escherichia coliKiyotaka Shiba, Koreaki Ito, Takashi Yura — 1986
• The tolZ gene of Escherichia coli is identified as the ftsH geneJiayi Qu, Sou‐ichi Makino, Hiroyuki Adachi — 1996
• Mutant of bacteriophage T4D affecting expression of many early genesT. Mattson, J. Paul Richardson, Douglas S. Goodin — 1974
• The future of ctDNA-defined minimal residual disease: Personalizing adjuvant therapy in CRCAlisha Bent, Shreya Raghavan, Arvind Dasari — 2022
• Response to comment on ‘KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'K-L.G. Spindler, Niels Pallisgaard, Rikke Fredslund Andersen — 2014
• Abstract 2522: Exploring the prognostic and predictive value of circulating tumor DNA in patients with advanced colorectal cancer and chemotherapyXiu Liu, Xuan Zhang, Kai Ou — 2021